N-ethyl-N-methyl-glycine ethyl ester | 59936-25-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-ethyl-N-methyl-glycine ethyl ester
• 英文别名: N-Aethyl-N-methyl-glycin-aethylester；(Methyl-aethyl-amino)-essigsaeure-aethylester；N-Aethyl-sarkosin-aethylester；Ethyl 2-[ethyl(methyl)amino]acetate
• CAS: 59936-25-3
• 化学式: C₇H₁₅NO₂
• 分子量: 145.202
• InChiKey: ATZRMJJFDRYNFI-UHFFFAOYSA-N

物化性质

• 沸点：
  69-70 °C(Press: 24 Torr)
• 密度：
  0.937±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  10
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-ethyl-N-methyl-glycine ethyl ester 在 盐酸 作用下， 生成 N-ethyl-N-methylglycine
  参考文献：
  名称：

  The Stereoisomerism of Complex Inorganic Compounds. XIV. Studies upon the Stereochemistry of Saturated Tervalent Nitrogen Compounds¹

  摘要：

  DOI：

  10.1021/ja01134a023
• 作为产物：
  描述：

  N-乙基甲基胺 、 溴乙酸乙酯 在 乙醚 作用下， 生成 N-ethyl-N-methyl-glycine ethyl ester
  参考文献：
  名称：

  O-ALKYL SUBSTITUTED HYDROXYLAMINO ACIDS, ESTERS AND ALCOHOLS¹

  摘要：

  DOI：

  10.1021/ja01366a036

文献信息

• DIHYDROPYRIMIDO LOOP DERIVATIVE AS HBV INHIBITOR
  申请人：MEDSHINE DISCOVERY INC.

  公开号：US20170197986A1

  公开（公告）日：2017-07-13

  Disclosed is a dihydropyrimido fused ring derivative as a HBV inhibitor, and in particular relates to a compound shown as formula (I) or a pharmaceutically acceptable salt thereof.

  本发明公开了一种二氢嘧啶并环衍生物作为HBV抑制剂，特别涉及一种如下式（I）所示的化合物或其药用可接受的盐。
• Hydrolytically-Resistant Boron-Containing Therapeutics And Methods Of Use
  申请人：Lee Ving

  公开号：US20070265226A1

  公开（公告）日：2007-11-15

  Compositions and methods of use of boron derivatives, including benzoxaboroles, benzazaboroles and benzthiaboroles, as therapeutic agents for treatment of diseases caused by fungi, yeast, bacteria or viruses are disclosed, as well as methods for synthesis of said agents and compositions thereof.

  揭示了硼衍生物的组合物和使用方法，包括苯硼酚酯、苯氮硼酚酯和苯硫硼酚酯，作为治疗由真菌、酵母、细菌或病毒引起的疾病的治疗剂，以及合成所述药剂和组合物的方法。
• MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS
  申请人：Busch-Petersen Jakob

  公开号：US20090258858A1

  公开（公告）日：2009-10-15

  Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.

  本发明提供了肌肉型乙酰胆碱受体拮抗剂及其使用方法。
• Aromatic Compounds
  申请人：Fukushima Tae

  公开号：US20070270422A1

  公开（公告）日：2007-11-22

  The present invention provides a novel compound, which has an excellent effect of suppressing the generation of collagen and less side effects, with being excellent in terms of safety. The compound of the present invention is represented by the following general formula (1): [wherein X 1 represents a nitrogen atom or a group —CH═; R 1 represents a group -Z-R 6 , wherein Z represents a group —CO—, a group —CH(OH)—, or the like, and R 6 represents a 5- to 15-membered monocyclic, dicyclic, or tricyclic, saturated or unsaturated heterocyclic group having 1 to 4 nitrogen atoms, oxygen atoms, or sulfur atoms; R 2 represents a hydrogen atom, a halogen atom or a lower alkylene group; Y represents a group —O—, a group —CO—, a group —CH(OH)—, a lower alkylene group, or the like; and A represents a group or the like, wherein R 3 represents a hydrogen atom, a lower alkoxy group, or the like, p represents 1 or 2, and R 4 represents an imidazolyl lower alkyl group or the like.

  本发明提供了一种新型化合物，具有抑制胶原生成的优异效果，并且具有较少的副作用，在安全性方面表现出色。本发明的化合物由以下通式（1）表示：[其中X1代表氮原子或基团—CH═；R1代表基团-Z-R6，其中Z代表基团—CO—、基团—CH(OH)—或类似基团，而R6代表具有1到4个氮原子、氧原子或硫原子的5-到15元的单环、双环或三环、饱和或不饱和杂环基团；R2代表氢原子、卤素原子或低碳链基团；Y代表基团—O—、基团—CO—、基团—CH(OH)—、低碳链基团或类似基团；A代表基团或类似基团，其中R3代表氢原子、低碳醚基团或类似基团，p代表1或2，而R4代表咪唑基低碳基团或类似基团。
• AROMATIC COMPOUND
  申请人：FUKUSHIMA Tae

  公开号：US20120238750A1

  公开（公告）日：2012-09-20

  The compound of the present invention is represented by the following general formula (1): [wherein X 1 represents a nitrogen atom or a group —CH═; R 1 represents a group —Z—R 6 , wherein Z represents a group —CO—, a group —CH(OH)—, or the like, and R 6 represents a 5- to 15-membered monocyclic, dicyclic, or tricyclic, saturated or unsaturated heterocyclic group having 1 to 4 nitrogen atoms, oxygen atoms, or sulfur atoms; R 2 represents a hydrogen atom, a halogen atom or a lower alkylene group; Y represents a group —O—, a group —CO—, a group —CH(OH)—, a lower alkylene group, or the like; and A represents a group or the like, wherein R 3 represents a hydrogen atom, a lower alkoxy group, or the like, p represents 1 or 2, and R 4 represents an imidazolyl lower alkyl group or the like.

  本发明的化合物由以下通式（1）表示：[其中X1表示氮原子或基团—CH═; R1表示基团—Z—R6，其中Z表示基团—CO—、基团—CH（OH）—或类似物，而R6表示具有1至4个氮原子、氧原子或硫原子的5至15环的单环、双环或三环、饱和或不饱和的杂环基团; R2表示氢原子、卤素原子或较低的烷基链; Y表示基团—O—、基团—CO—、基团—CH（OH）—、较低的烷基链或类似物; A表示基团或类似物，其中R3表示氢原子、较低的烷氧基或类似物，p表示1或2，而R4表示咪唑基较低的烷基链或类似物。